A rapidly growing body of research is showing that most dementia cases are preventable, says Jacob Teitelbaum, M.D. Read on ...

Determining the specific type of dementia early in the diagnostic process can lead to more targeted treatments and better outcomes ...

When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle weakness, assuming that could be a sig ...

A brain bleed and subsequent brain surgery many decades ago may have led to cognitive impairment in the former president.

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge step forward in research because they target a known cause of the disease, ...

Breakthrough Alzheimer’s drugs rejected for use on the NHS. Here’s how they work - Scientists and doctors remain divided on ...

Robert F. Kennedy Jr. painted a bleak picture of people with autism spectrum disorder, or ASD, that was especially hurtful to ...

We’re not going to find a smoking gun that is going to explain the incidence of autism. And it’s certainly not going to be ...

Coaching legend Marty Schottenheimer battled Alzheimer's in the final years of his life. His family continues to fundraise towards finding a cure. Coach Schottenheimer died of the disease in 2021.

JACKSONVILLE, Fla. — Alzheimer's disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, devastates patients, their families and loved ones ...

Long praised in the kitchen, rosemary is gaining scientific attention for its brain-boosting properties. Recent studies show it may support memory, protect neurons, and even reduce Alzheimer’s-related ...

A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and efficacy endpoints, prompting the Sanofi-bound biotech to stop a long-term extension trial of the TREM2 agonist.